Leading PCD Pharma Franchise Companies in India.

VOGLICOP M 0.3/500

Composition Voglibose 0.3mg
Metformin Hydrochloride 500mg
Dosage TABLET
Packing Size 20×10
Packing Blister

Additional information

VOGLICOP M 0.3/500 Tablets

VOGLICOP M 0.3/500 is a powerful antidiabetic combination tablet designed to support effective management of type 2 diabetes. It combines two active ingredients in a precise 0.3/500 mg dosage to regulate blood sugar levels and improve overall glycemic control.

This formulation works by enhancing insulin sensitivity and reducing glucose production in the liver, providing consistent blood sugar management throughout the day. VOGLICOP M 0.3/500 is suitable for patients who need a comprehensive approach to controlling diabetes beyond monotherapy.

Regular use of VOGLICOP M 0.3/500 helps prevent sudden blood sugar spikes and dips, reducing the risk of long-term complications such as kidney problems, neuropathy, and cardiovascular issues. It is often prescribed as part of a holistic diabetes care plan, including diet, exercise, and routine monitoring of glucose levels.

Patients appreciate VOGLICOP M 0.3/500 for its reliable efficacy and convenient dosage, which supports adherence to daily treatment. With its well-balanced formulation, VOGLICOP M 0.3/500 Tablets provide a safe and effective solution for maintaining healthy blood sugar levels, promoting overall wellness and improving quality of life for individuals managing type 2 diabetes.